Guidance for HIV sales growth increased to approximately 6% for 2026, up from prior expectations, while Yeztugo's revenue target increased markedly from $150 million to $800 million for the next year.

The Philly Keep on Loving HIV Resource Finder compiles a wide range of services administered through the Health Department ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Gilead Sciences Inc. forecast 2026 product revenue and profit that missed analysts’ expectations, even after it outperformed ...

City of Durham reports and correspondence show few people have received federal HIV/AIDS housing assistance, despite the city ...

In a federally funded clinical trial led by Johns Hopkins Medicine, people with tuberculosis infections (but not HIV) in two ...

Harley Ransom began practicing harm reduction in southeastern Ontario in the late 1980s, when he was 6 years old. His ...

Today, that fight continues as Indiana confronts the urgent need to reform its HIV criminal laws and remove stigma from our ...

By Sydney Byerly The Indiana Citizen February 9, 2026 A conservative split over syringe exchanges is resurfacing this year, ...

Frank discussions around sex, pleasure, trans solidarity, and improved medical care could all help ease HIV's ...

Out of the Closet, a nonprofit thrift store operated by the AIDS Healthcare Foundation, opened in the neighborhood last ...

Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...